Literature DB >> 18626651

Evaluation of alpha-synuclein immunohistochemical methods used by invited experts.

Thomas G Beach1, Charles L White, Ronald L Hamilton, John E Duda, Takeshi Iwatsubo, Dennis W Dickson, James B Leverenz, Federico Roncaroli, Manuel Buttini, Christa L Hladik, Lucia I Sue, Joseph V Noorigian, Charles H Adler.   

Abstract

The use of alpha-synuclein immunohistochemistry has altered our concepts of the cellular pathology, anatomical distribution and prevalence of Lewy body disorders. However, the diversity of methodology between laboratories has led to some inconsistencies in the literature. Adoption of uniformly sensitive methods may resolve some of these differences. Eight different immunohistochemical methods for demonstrating alpha-synuclein pathology, developed in eight separate expert laboratories, were evaluated for their sensitivity for neuronal elements affected by human Lewy body disorders. Identical test sets of formalin-fixed, paraffin-embedded sections from subjects diagnosed neuropathologically with or without Lewy body disorders were stained with the eight methods and graded by three observers for specific and nonspecific staining. The methods did not differ significantly in terms of Lewy body counts, but varied considerably in their ability to reveal neuropil elements such as fibers and dots. One method was clearly superior for revealing these neuropil elements and the critical factor contributing to its high sensitivity was considered to be its use of proteinase K as an epitope retrieval method. Some methods, however, achieved relatively high sensitivities with optimized formic acid protocols combined with a hydrolytic step. One method was developed that allows high sensitivity with commercially available reagents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626651      PMCID: PMC2708176          DOI: 10.1007/s00401-008-0409-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  49 in total

1.  Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry.

Authors:  E Iseki; W Marui; H Akiyama; K Uéda; K Kosaka
Journal:  Neurosci Lett       Date:  2000-05-26       Impact factor: 3.046

2.  Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability.

Authors:  Christian M Müller; Rob A I de Vos; Claude-Alain Maurage; Dietmar R Thal; Markus Tolnay; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2005-07       Impact factor: 3.685

3.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

Authors:  M Baba; S Nakajo; P H Tu; T Tomita; K Nakaya; V M Lee; J Q Trojanowski; T Iwatsubo
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

Review 4.  Alpha-synuclein in Lewy body disease and Alzheimer's disease.

Authors:  M Hashimoto; E Masliah
Journal:  Brain Pathol       Date:  1999-10       Impact factor: 6.508

5.  Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.

Authors:  Laura Parkkinen; Hilkka Soininen; Irina Alafuzoff
Journal:  J Neuropathol Exp Neurol       Date:  2003-04       Impact factor: 3.685

6.  Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease.

Authors:  E Iseki; W Marui; K Kosaka; H Akiyama; K Ueda; T Iwatsubo
Journal:  Neurosci Lett       Date:  1998-12-18       Impact factor: 3.046

Review 7.  Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.

Authors:  Glenda M Halliday; Heather McCann
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

8.  Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

Authors:  John E Duda; Benoit I Giasson; Meghann E Mabon; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

9.  Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient.

Authors:  James B Leverenz; Ronald Hamilton; Debby W Tsuang; Aimee Schantz; Darcy Vavrek; Eric B Larson; Walter A Kukull; Oscar Lopez; Douglas Galasko; Eliezer Masliah; Jeffrey Kaye; Randall Woltjer; Christopher Clark; John Q Trojanowski; Thomas J Montine
Journal:  Brain Pathol       Date:  2008-01-29       Impact factor: 6.508

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  90 in total

1.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Authors:  Thomas J Montine; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; John Q Trojanowski; Harry V Vinters; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2011-11-20       Impact factor: 17.088

2.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Authors:  Bradley T Hyman; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Maria C Carrillo; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; Bill Thies; John Q Trojanowski; Harry V Vinters; Thomas J Montine
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

3.  Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.

Authors:  Brittany N Dugger; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2010-08-19       Impact factor: 17.088

4.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

5.  Alpha-synuclein expression patterns in the colonic submucosal plexus of the aging Fischer 344 rat: implications for biopsies in aging and neurodegenerative disorders?

Authors:  R J Phillips; F N Martin; C N Billingsley; T L Powley
Journal:  Neurogastroenterol Motil       Date:  2013-06-30       Impact factor: 3.598

Review 6.  Skin nerve α-synuclein deposits in Parkinson's disease and other synucleinopathies: a review.

Authors:  Vincenzo Donadio
Journal:  Clin Auton Res       Date:  2018-11-30       Impact factor: 4.435

7.  Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?

Authors:  Roberta Frigerio; Hiroshige Fujishiro; Tae-Beom Ahn; Keith A Josephs; Demetrius M Maraganore; Anthony DelleDonne; Joseph E Parisi; Kevin J Klos; Bradley F Boeve; Dennis W Dickson; J Eric Ahlskog
Journal:  Neurobiol Aging       Date:  2009-06-26       Impact factor: 4.673

8.  BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brains.

Authors:  Boris Decourt; Amanda Gonzales; Thomas G Beach; Michael Malek-Ahmadi; Aaron Walker; Lucia Sue; Douglas G Walker; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2013-03       Impact factor: 3.498

9.  Urban air pollution: influences on olfactory function and pathology in exposed children and young adults.

Authors:  Lilian Calderón-Garcidueñas; Maricela Franco-Lira; Carlos Henríquez-Roldán; Norma Osnaya; Angelica González-Maciel; Rafael Reynoso-Robles; Rafael Villarreal-Calderon; Lou Herritt; Diane Brooks; Sheyla Keefe; Juan Palacios-Moreno; Rodolfo Villarreal-Calderon; Ricardo Torres-Jardón; Humberto Medina-Cortina; Ricardo Delgado-Chávez; Mario Aiello-Mora; Robert R Maronpot; Richard L Doty
Journal:  Exp Toxicol Pathol       Date:  2009-03-17

10.  The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition.

Authors:  Virginie Loeb; Eugenia Yakunin; Ann Saada; Ronit Sharon
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.